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Abstract
In the last years, the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene has been asso-
ciated with epileptic encephalopathies characterized by the early onset of intractable epi-
lepsy, severe developmental delay, autistic features, and often the development of Rett
syndrome-like features. Still, the role of CDKL5 in neuronal functions is not fully understood.
By way of a yeast two hybrid screening we identified the interaction of CDKL5 with shootin1,
a brain specific protein acting as a determinant of axon formation during neuronal polariza-
tion. We found evidence that CDKL5 is involved, at least in part, in regulating neuronal
polarization through its interaction with shootin1. Indeed, the two proteins interact in vivo
and both are localized in the distal tip of outgrowing axons. By using primary hippocampal
neurons as model system we find that adequate CDKL5 levels are required for axon specifi-
cation. In fact, a significant number of neurons overexpressing CDKL5 is characterized by
supernumerary axons, while the silencing of CDKL5 disrupts neuronal polarization. Interest-
ingly, shootin1 phosphorylation is reduced in neurons silenced for CDKL5 suggesting that
the kinase affects, directly or indirectly, the post-translational modification of shootin1.
Finally, we find that the capacity of CDKL5 to generate surplus axons is attenuated in neu-
rons with reduced shootin1 levels, in agreement with the notion that two proteins act in a
common pathway. Altogether, these results point to a role of CDKL5 in the early steps of
neuronal differentiation that can be explained, at least in part, by its association with
shootin1.
Introduction
During the last years, the cyclin-dependent kinase-like 5 gene (CDKL5; OMIM 300203),
located on the X-chromosome, has been associated with severe encephalopathy associated with
X-linked infantile spasms and some Rett syndrome (RTT)-like features [1,2]. CDKL5 is a
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serine/threonine kinase with an N-terminal catalytic domain that shares homology with the
mitogen-activated protein kinases and cyclin-dependent kinases [3]. The long C-terminal
region of CDKL5 regulates several aspects of its properties such as catalytic activity, subcellular
localization, and protein stability [4–6].
In accordance with its involvement in intellectual disability, CDKL5 is highly abundant in
brain where it is significantly induced in early post-natal stages suggesting a role in brain matu-
ration [7,8]. The high levels of CDKL5 in brain can be attributed predominantly to neuronal
expression since only low levels are present in glial cells. CDKL5 is involved in neuronal mor-
phogenesis and dendritic arborization in a Rac1 dependent manner, as shown by its silencing
in primary neurons [9]. Moreover, proper spine development and synapse formation was
found to depend on the presence of functional CDKL5 in accordance with its accumulation in
the post-synaptic densities of mature neurons [10,11]. Recently, two knockout mouse models
of Cdkl5 have been developed [12,13]. These mice do not show gross general changes or brain
morphology defects, but exhibit reduced dendritic branching and outgrowth, together with
defects in neural circuit communication. Interestingly, both Cdkl5-null mouse models display
some behavioral deficits such as autistic-like features and impaired learning and memory while
spontaneous seizures, which represent the most striking phenotype in humans, are absent.
Despite a clear involvement of CDKL5 in shaping the dendritic arbor and synaptic spines, its
role in the early phases of neuronal development, when the axon is specified, is poorly
described.
Primary hippocampal neurons have been instrumental to identify cellular and molecular
changes involved in generating neuronal polarity [14,15], leading to the establishment of one
axon and several dendrites per neuron. Dissociated embryonic hippocampal neurons form sev-
eral immature neurites upon plating. The early steps of their spontaneous polarization involve
the breaking of neuronal symmetry leading to the accumulation of distinct proteins in the
axon-to-be [16]. Here we present evidence that both increased and reduced levels of CDKL5
are detrimental for the correct progression of these events, clearly suggesting a role of the
kinase in the proper establishment of neuronal polarity. This effect depends, at least in part, on
the association of CDKL5 with shootin1, a key protein in neuronal polarization [17,18].
Accordingly, neurons with altered CDKL5 levels show polarization defects that partially over-
lap those of shootin1. Altogether, our data provide novel insights in the role of CDKL5 for
proper brain functions and suggest that the loss of CDKL5 might impact neuronal differentia-
tion during very early developmental stages.
Materials and Methods
Ethics Statement
Protocols and use of animals were approved by the Animal Ethics Committee of the University
of Insubria and in accordance with the guidelines released by the Italian Ministry of Health.
Adult mice were euthanized by cervical dislocation, while neonates were sacrificed by exposure
to CO2 followed by decapitation.
Reagent and Antibodies
The following primary antibodies were used in immunofluorescence and western blotting
experiments: custom-made immunopurified anti-CDKL5, used for coimmunoprecipitation
experiments, has been described elsewhere [8]. Anti-CDKL5 (HPA002847, Sigma-Aldrich),
chicken anti-GFP (A10262, Life Technologies), anti-P-ERK (9101S, Cell Signaling), anti-shoo-
tin1 (PA5-17167 (rabbit) Thermo; 3279 (rabbit) Cell Signaling; sc244129 (goat) Santa Cruz),
anti-Tau1 (MAB3420, Millipore), anti-MAP2 (ab11267, Abcam), anti-NFL (MA5-14981,
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Thermo Scientific), anti-Tuj1 (MMS-435P, Covance), anti-β-actin (A5441, Sigma-Aldrich).
DAPI and secondary Alexa Fluor anti-rabbit, anti-mouse, anti-chicken and anti-goat antibod-
ies for immunofluorescence experiments were purchased from Life Technologies. HRP-conju-
gated secondary anti-mouse, anti-rabbit, and anti-goat antibodies for western blottings were
obtained from Thermo Scientific.
Yeast Two-Hybrid Screening
The yeast two-hybrid screening was performed by Hybrigenics Services, S.A.S, Paris, France
(http://www.hybrigenics-services.com). The C-terminus of human CDKL5 (amino acids 299–
1030; GenBank accession number gi: 83367068) fused to the Gal4 DNA-binding domain and
expressed from the inducible pB35 vector, was used as bait to screen a random-primed Human
Adult Brain cDNA library constructed into pP6.
113 million clones (11-fold the complexity of the library) were screened using a mating
approach with Y187 (MATα Gal4Δ Gal80Δ ade2-101 his3 leu2-3,-112 trp1-901 ura3-52
URA3::UASGAL1-LacZ, (met-)) and CG1945 (MATa Gal4-452 Gal80-538 ade2-101
his3-D200 leu2-3,112 trp1-901 ura3-52 lys2-801 URA3::Gal4 17mers (X3)-CyC1TATA-LacZ
lys2::GAL1UAS-GAL1TATA-HIS3 cyhR) yeast strains. A total of 171 His+ colonies were
selected on a medium lacking tryptophan, leucine, methionine and histidine. The prey frag-
ments of the positive clones were amplified by PCR and sequenced at their 5’ and 3’ junctions.
The resulting sequences were used to identify the corresponding interacting proteins in the
GenBank database (NCBI) using a fully automated procedure. A confidence score (PBS, for
Predicted Biological Score) was attributed to each interaction as previously described [19].
Plasmids and Constructs
Flag-CDKL5 (107 kDa isoform) has been described elsewhere [6]. pCAGGS-CDKL5-ires-GFP
was cloned by inserting an EcoRI-EcoRV digested PCR product containing the murine CDKL5
cDNA (NP_001019795) into pCAGGS-ires-GFP digested with EcoRI and SmaI. The K42R
derivative was generated by site-directed mutagenesis using the QuickChange site-directed
mutagenesis kit (Stratagene). pCAGGS-shootin1-ires-GFP was cloned likewise by inserting
PCR amplified human shootin1 (NM_018330) into the EcoRI-SmaI digested vector. Lentiviral
vectors to silence endogenous CDKL5 and shootin1 were generated by cloning double stranded
oligonucleotides into the HpaI and XhoI sites of pLentiLox 3.7 (pLL 3.7). The target sequences
of the shRNAs are as follows: shCDKL5#1: CTATGGAGTTGTACTTAA; shCDKL5#2: GTGA
GAGCGAAAGGCCTT; shCDKL5#3: GCAGAGTCGGCACAGCTAT; shShootin1#1: 5’-CCA
CGGTGAATAAATAGAAAT (against the 3’UTR); shShootin1#2: GCAGAACCATCTTGAA
ATA; a shRNA against LacZ was used as control. All PCR derived constructs were sequence
verified.
Primary Neuronal Cultures
Primary hippocampal cultures were prepared from embryonic day 16 (E16) CD1 mouse
embryos, considering the day of the vaginal plug as E0, as described previously [5] and plated
on poly-L-lysine coated dishes at different densities: 2x103/cm2 for immunostainings and
1x104/cm2 for western blots. For overexpression studies, hippocampal neurons were trans-
fected at 0 days in vitro (DIV0) by nucleofection using the Amaxa Basic Neuron Small Cell
Number Nucleofector Kit following the manufacturer’s instructions. Embryos at E17 were
used in this case to make neurons more resistant to the nucleofection process. Infection of hip-
pocampal and cortical neurons was performed by adding lentiviral particles to the neurons
before plating or 10 h after nucleofection.
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Immunoprecipitations
Immunoprecipitation of endogenous CDKL5 from P7 mouse brains was performed by homog-
enizing the whole brain in lysis buffer (50 mM Tris-HCl pH 7.5; 150 mMNaCl, 1 mM EDTA,
1mM EGTA, 1% Triton X-100, 0.1% SDS, 2 mM sodium pyrophosphate, 1 mM sodium ortho-
vanadate), incubation on ice for 20 min and centrifugation at 100.000 g for 30 min at 4°C. The
mouse brain extract (500 μg) was incubated overnight at 4°C with 20 μl purified anti-CDKL5
[8] or unrelated IgGs as control. The immunocomplexes were precipitated with protein-G Aga-
rose (Life Technologies), washed with lysis buffer and analyzed by SDS-PAGE. Shootin1 was
immunoprecipiated from P5 brains lysed in the above lysis buffer (w/o SDS) with anti-shootin1
(Thermo Scientific) or unrelated IgGs as control. The protein-G agarose resin was saturated
with 5% BSA in PBS before being added to the immunocomplexes. Goat anti-shootin1 was
used to detect immunoprecipitated shootin1.
Exogenously expressed Flag-CDKL5 was immunoprecipitated from transfected HeLa cells
lysed in lysis buffer (NaCl 150 mM, Trish pH 8 50 mM, Triton 1%, EDTA 2 mMwith protease
inhibitor cocktail (Sigma Aldrich) and PhosStop (Roche)). The sonicated lysate was centrifu-
gated and the obtained whole cell extract pre-cleared with Protein-G agarose (Thermo Scien-
tific). The anti-Flag resin (Sigma Aldrich) was blocked with 5% BSA in PBS for 4 h where after
it was added to the pre-cleared extract. After over night incubation the immunocomplexes
were washed several times with wash buffer (400 mMNaCl, 50 mM Tris-HCL pH 8, 1% Tri-
ton, 2 mM EDTA, protease inhibitor cocktail), once with PBS and separated on a 8%
SDS-PAGE.
Immunofluorescence
Primary neurons were fixed in 4% paraformaldehyde for 10 min, blocked for 1 h (5% horse
serum, 0.2% Triton X-100, phosphate buffer), then incubated overnight at 4°C with the pri-
mary antibody in phosphate buffer, 5% horse serum and 0.2% Triton X-100 and finally with
the corresponding secondary antibodies. Nuclei were stained with DAPI and the cells mounted
for microscopy analysis at a Nikon Eclipse Ni microscope equipped with a Nikon Digital Sight
DS-2MBWc camera. Neuronal polarization was analyzed by staining with Tau1 and MAP2
(axon and dendrite specific markers, respectively). Neurites longer than 100 μm in which the
intensity of Tau-1 staining increased significantly along the proximal to distal axis were
counted as axons. According to this parameter, neurons were classified either as lacking an
axon (no axon) when none of the neurites could be considered an axon or with multiple axons
when more than one neurite showed the properties of an axon. Image analysis was performed
with Adobe Photoshop and IMAGE J (http://rsbweb.nih.gov/ij/).
In situ hybridization
Antisense riboprobes against mouse Cdkl5 and shootin1 (both full length) were used to stain
for endogenous mRNAs. In situ hybridizations were run on slide mounted cryostat sections
(12 μm) using a protocol based on a previous published paper [20].
Two-Dimensional Isoelectric Focusing
2.5x106 cortical neurons isolated from E16 mouse embryos were infected at DIV0 to silence
CDKL5 expression. At DIV7, cells were washed and lysed in UTC buffer (7 M urea, 2 M thio-
urea, 4% CHAPS). Approximately 200 μg of extract were loaded on 7 cm IPG DryStrips with a
linear 4–7 pH gradient and isoelectric focusing performed with an IPGphor II apparatus (GE
Healthcare) according to the manufacturer’s instructions. Subsequent SDS-PAGE was
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performed using 8% gels and proteins were detected by western blotting. Phosphatase treat-
ment was done by adding 100 units of Lambda Protein Phosphatase (Lambda PP; New
England Biolabs) to the extract diluted in 2 ml 0.1% SDS, 0.1 mMMnCl2, and 1x phosphatase-
buffer. After an overnight incubation at 30°C the samples were concentrated with Ultracel 10K
centrifugal filters (Millipore) and subjected to isoelectric focusing.
Virus Preparation
HEK293T cells, grown in 150 mm dishes, were cotransfected with the packaging vectors
pVSV-G, pMDL, pREV and either pLL3.7-shCDKL5#1, pLL3.7-shCDKL5#2,
pLL3.7-shCDKL5#3, pLL3.7-shShootin#1, pLL3.7-shShootin#2, or pLL3.7-shLacZ using cal-
cium phosphate. The viral particles were harvested 36 h post-transfection and concentrated by
ultracentrifugation with SW32 rotor (Beckman Instruments) at 20.000 rpm for 2 h. Viruses
were resuspended in PBS and stored at -80°C.
Statistical Analysis
Values are expressed as means ± standard error (SEM). The significance of results was obtained
by Student’s t test and ANOVA two-way followed by Tuckey’s post-hoc test. Statistical signifi-
cance was established as p< 0.05.
Results
Shootin1 is a novel interactor of CDKL5 in vivo
To elucidate the neuronal functions of CDKL5 we searched for interacting proteins through a
yeast two-hybrid screening. The C-terminal region of human CDKL5 (amino acids 299–1030)
regulates its activities and serves as interfase with MeCP2, DNMT1, and PSD95 [7,21,11]. We
therefore used this region as bait to screen a human adult brain cDNA library. We obtained
171 interacting clones of which shootin1 obtained the highest confidence score. Shootin1 was
previously described as a brain-specific protein that is involved in axon formation and neuro-
nal polarization [17,18]. A total of seven clones containing different but overlapping regions of
shootin1 were picked in the screening enabling us to map the central region, spanning amino
acids 53–290, as the surface that contacts CDKL5 (Fig 1A). To confirm a physical interaction
between the two proteins in vivo, lysates from P7 brains were used to immunoprecipitate
CDKL5. Subsequent western blotting specifically detected shootin1 in the CDKL5 immunopre-
cipiate (Fig 1B, upper panel). The reciprocal experiment, in which CDKL5 copurified with
shootin1 (Fig 1B, lower panel), confirmed that the two proteins associate in a common com-
plex in mouse brain. Further evidence of the capacity of CDKL5 and shootin1 to interact was
obtained by coimmunoprecipitating the overexpressed proteins from transfected HeLa cells
(Fig 1C).
To evaluate when a physical association between the two proteins might exist in vivo, we
compared their temporal expression pattern during brain maturation. By immunoblotting
lysates of mouse brains at different developmental stages we observed that shootin1 was
strongly expressed from E18 until P7 when its levels started declining becoming undetectable
in the adult brain (Fig 2A). In accordance with our previous results, CDKL5 expression was
strongly induced in the first post-natal days [5] and a prominent coexpression of the two pro-
teins was observed in the early post-natal stages from P4 to P14.
We then compared the expression pattern of Cdkl5 and shootin1 in the developing cortex
by in situ hybridization (Fig 2B). In line with a previous report [22], shootin1 transcripts were
detected as early as E13 where its expression overlapped with that of Cdkl5 in post-mitotic
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cortical neurons both migrating out of the proliferative zone (ventricular and sub-ventricular
zones, VZ and SVZ) and residing in the cortical plate (CP). At E18 high levels of both shootin1
and Cdkl5mRNAs were detected in the cortex, further suggesting that shootin1 and CDKL5
may be expressed by the same neurons, supporting the notion of their in vivo interaction.
To assess in more details whether both CDKL5 and shootin1 are physically present in neu-
rons during the first stages of neuronal differentiation, we analyzed their expression in primary
hippocampal neurons prepared from E16 mouse brains and collected at different time points
(Fig 2C). Both shootin1 and CDKL5 levels are low but detectable 18 h after plating but are con-
comitantly induced between 40–72 h of culturing and reach a plateau of expression at DIV7.
We next analyzed the localization of the two proteins in cultured hippocampal neurons at
the initial stages after plating (Fig 2D). In stage 2 neurons, before axon specification occurs, we
detected shootin1 in the distal tip of minor processes, as expected, besides its presence in the
nucleus and soma [17]. Later, when the axon has been specified (stage 2.5) and when axon out-
growth is clearly detectable (stage 3), shootin1 presented a clear accumulation in the axonal
growth cone. Although CDKL5 did not accumulate in the distal tip of minor processes and
axonal growth cones, it could easily be detected all along these processes from the soma to the
distal tip (S1 Fig) where it partially colocalized with shootin1 (Fig 2D).
Altogether, these data indicate the existence of a concurrent spatial and temporal expression
profile for CDKL5 and shootin1, supporting the notion of a physical interaction between the
two proteins.
Neuronal polarization depends on proper CDKL5 levels
Shootin1 has a well-established role in regulating axon formation. Its interaction with CDKL5
prompted us to study the role of the kinase for neuronal polarization using loss- and gain-of-
function approaches in hippocampal neuronal cultures. We first analyzed the effect of reduced
Fig 1. CDKL5 interacts with shootin1 in vivo. (A) A yeast two-hybrid screening identified shootin1 as a CDKL5 interacting protein. The C-terminal region of
hCDKL5, spanning amino acids 299–1030, was used as bait (upper, thick bar). The diagram below shows shootin1 with its coiled coil domains in black. The
clones identified in the screen are indicated as black bars and the minimumCDKL5 interacting region as a black bar. (B) Coimmunoprecipitation of P5-7 brain
lysates with anti-CDKL5 (upper, n = 3) or anti-shootin1 (lower, n = 3) antibodies (both rabbit). IgGs were used as negative control. The immunoprecipitates
and inputs (5% of the brain lysates) were analyzed by immunoblotting for CDKL5 and shootin1 (using a goat anti-shootin1 antibody). Asterisks indicate the
immunoglobulin heavy chains and the open circle an unspecific band detected with anti-CDKL5. (C) Coimmunoprecipitation of HeLa cells overexpressing
either Flag-CDKL5 or shootin1 or both proteins together. Whole cell lysates were immunoprecipiated with an anti-Flag resin and inputs (5%) and
immunocomplexes analyzed by western blotting as indicated. Asterisk shows an anti-shootin1 reactive protein that copurifies with CDKL5. (n = 3).
doi:10.1371/journal.pone.0148634.g001
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Fig 2. CDKL5 and shootin1 are coexpressed in brains and neurons. (A) Western blot analysis showing CDKL5 and shootin1 levels in mouse brain at the
indicated developmental stages using Tuj1 as loading control. (n = 2) (B) Shootin1 is expressed in the cortex, as early as E13, in the cortical plate (cp) and its
levels increase ongoing with development (a,b,c,d); Cdkl5 (b’,c’,d’) follow the same pattern. Low but detectable levels of shootin1 andCdkl5mRNAs are
present in cells migrating out of the ventricular and sub-ventricular zone (vz-svz) towards their final destination in the cortical plate (b,b’). At E18 shootin1 and
Cdkl5 are strongly expressed throughout the whole thickness of the cortex (d,d’). Scale bars: 50 μm: b,b’,c,c’; 100 μm: d,d’; 200 μm: a. (C) Western blot
showing CDKL5 and shootin1 levels in cultured primary hippocampal neurons at the indicated stages. A longer exposure of the 18 h time point is shown to
the right. (n = 2). (D) Immunofluorescence analysis (left) of hippocampal neurons at stages 2–3 with antibodies against CDKL5 (green) and shootin1 (red).
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CDKL5 levels for neuronal polarization. CDKL5, shootin1 or, as control, LacZ were silenced by
infecting primary hippocampal cultures, prepared from E16 mouse embryos, with lentiviral
particles expressing specific shRNAs. The efficient silencing of CDKL5 and shootin1 was veri-
fied by immunoblotting lysates prepared 96 h after infection with three shRNAs against
CDKL5 and two against shootin1 (Fig 3A). At DIV4, infected GFP-positive neurons silenced
for CDKL5 (Fig 3B) presented an altered morphology as compared to controls. As expected,
neurons silenced for shootin1 appeared severely stunted, lacking any long process and display-
ing several short neurites.
We then analyzed how the loss of CDKL5 or shootin1 influenced axon specification by
immunostaining with the axonal and dendritic markers, Tau1 and MAP2, respectively. Cor-
rectly polarized neurons were recognized as bearing a single axon with a strong distal staining
for Tau1 and several minor MAP2 positive neurites, whereas others contained multiple axons
or no axon (S2 Fig). As expected, at DIV4, axon specification had occurred in the vast majority
of control neurons (means ±SEM: 90.32±0.63%) that extended a single axon with an average
length of 366±17.7 μm and several minor neurites (Fig 3C and 3D). In accordance with previ-
ous publications [17], the silencing of shootin1 interfered with axon specification and less than
60% of neurons carried one single, shorter axon (average length = 176±19.7 μm). Importantly,
the silencing of CDKL5 with all three shRNAs also significantly interfered with neuronal
polarization (polarized neurons means ±SEM: 59.53±3.42, 76.68±1.85 and 73.6±3.6% with
shCDKL5 #1, #2 and #3, respectively). CDKL5 silencing increased the percentage of neurons
bearing no axon (10.67±0.95, 10.35±2.25 and 10.08±1.61%, respectively, with shCDKL5 #1,
#2 and #3). However, the depletion of CDKL5 also gave rise to neurons with supernumerary
Tau1-positive and MAP2-negative axons (means ±SEM: 29.80±3.21, 12.90±1.95 and 16.58
±2.42% with shCDKL5 #1, #2, #3, respectively) (Fig 3B and 3C; S2 Fig). The mean length of the
longest axon in this group of CDKL5-depleted neurons was significantly shorter than that of
control neurons (240±11.1 μm; Fig 3D). Since this might be caused by the presence of a surplus
of axons limiting the amount of structural components, we also measured axon length in
shCDKL5#1-expressing neurons bearing only one axon (Fig 3E). Also in this case, axon length
was significantly reduced (shLacZ: 366±17.7 μm; shCDKL5#1: 223±11.2 μm) suggesting that
CDKL5 is required for both axon specification and axonal outgrowth. The effect of reduced
shootin1 levels on axon specification was only temporary since by DIV7 polarization levels
similar to those of control cells was restored [17]. On the other hand, we found that the
impairment caused by CDKL5 silencing persisted until DIV7 (polarized: shLacZ, 94.43±1.5%;
shCDKL5#1, 61.13±3.3%; shCDKL5#2, 73.1±5.52%; S3 Fig). Interestingly, at DIV7 the defect
could mostly be ascribed to neurons with a surplus of axons (shLacZ: 3.25±1.25%, shCDKL5#1:
38.35±2.88%; shCDKL5#2: 20.4±9.4%) whereas the number of neurons with no axon was
decreased (shLacZ: 1.73±1.02%; shCDKL5#1: 4.30±1.48%; shCDKL5#2: 6.5±2.65%) suggesting
that the underlying molecular defects are distinct and differently influenced by neuronal
maturation.
We next analyzed the effect of increased CDKL5 levels on neuronal polarization. To investi-
gate the relevance of the catalytic activity of CDKL5 we also expressed a kinase-dead derivative
(K42R), carrying a mutation in a critical residue of the ATP-binding site [4]. Primary hippo-
campal neurons were thus nucleofected at the time of plating with a construct expressing
mCDKL5 (or the kinase-dead mutant) and GFP from a bicistronic cassette. The GFP-vector
without CDKL5 was used as control. CDKL5 expression and neuronal morphology were
The small panels show the magnification of the minor processes/axons indicated with asterisks. Quantitative profiles showing the fluorescence intensities of
shootin1 (red) and CDKL5 (green) from the soma to the distal tip of the neurites/axons indicated with asterisks are shown to the right. Scale bar: 10 μm.
doi:10.1371/journal.pone.0148634.g002
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Fig 3. CDKL5 knock-down causes aberrant neuronal polarization. (A) Western blot showing CDKL5 and shootin1 levels in primary hippocampal neurons
infected with shRNAs against CDKL5, shootin1 or, as control, LacZ. Neurons were infected at DIV0 and cell lysates prepared after 96 h. Tuj1 was used as
loading control. The graph shows the quantified protein levels as means of n3 experiments, *p<0,05, **p<0,01, ***p<0,001 (Student’s t test). (B)
Representative images of neurons 96 h after plating and infection of viral particles expressing GFP together with shRNAs against LacZ, CDKL5 or shootin1.
The image is a composed panel of GFP-positive neurons. Scale bar: 50 μm. (C) Graph showing polarization of neurons expressing shRNAs against LacZ,
CDKL5 or shootin1. Polarized neurons are indicated with black bars, those with numerous axons with dark grey bars and neurons with no axon with light grey
bars. Data present percentage of neurons as means ±SEM (n250 neurons/condition from n3 experiments), *p<0,05, **p<0,01, ***p<0,001 (Student’s t
test). (D) Quantification of the length of the longest axon and dendrite of shRNA-expressing neurons. Data present neurite length as means ±SEM (a total of
110 neurons were analyzed in 4 independent experiments). (E) Neurite length of GFP-positive neurons bearing one axon (a total of 74 neurons were
analyzed in 3 independent experiments). Data in D and E present neurite length as means ±SEM, *, p<0,05, ***p<0.001. (Student’s t test).
doi:10.1371/journal.pone.0148634.g003
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analyzed at DIV5 by western blotting and immunofluorescence (IF; Fig 4A–4C). By IF we veri-
fied that GFP-positive transfected cells expressed increased amounts of CDKL5 and that the
exogenously expressed CDKL5-derivatives displayed the same typical dot-like staining in the
soma of the endogenous protein (Fig 4B and 4C). Most of the GFP-positive control neurons
were correctly polarized extending only a single axon (means ±SEM: 88.15±2.3%) with an aver-
age length of 326±25.8 μm (Fig 4C–4E). On the contrary, the morphology of GFP-positive
CDKL5 overexpressing neurons was significantly altered as we detected a large number of neu-
rons, harboring several long Tau1-positive processes (means ±SEM: polarized, 58.36±1.21%;
multiple axons, 40.56±0.3%). The mean length of the longest axon (232±14,97 μm) was signifi-
cantly shorter than that of control neurons (Fig 4E). Multiple axons were also detected in neu-
rons expressing the kinase dead CDKL5-K42R derivative (means ±SEM: polarized, 70.88
±3.33%; multiple axons, 28.38±3.2%), but the effect was significantly reduced when compared
to neurons expressing the wild-type protein (Fig 4D). Altogether, these data show that CDKL5
promotes axon formation and that its catalytic activity is involved.
CDKL5 and shootin1 work in common pathway
The above data suggest that CDKL5 might, at least partially, regulate axon formation through
its association with shootin1. Therefore we asked whether the two proteins work in a common
molecular pathway. We hypothesized that CDKL5 might promote axon specification only in
the presence of shootin1, thus working upstream of shootin1. We therefore overexpressed
CDKL5 in neurons in which shootin1 was silenced and analyzed neuronal polarization at
DIV5. Neurons were nucleofected at the day of plating with CDKL5- or GFP-expressing vec-
tors and, after another ten hours, infected with lentiviral particles expressing shShootin1#1 or
shLacZ as control. As expected, a significant number of neurons expressing shLacZ and exoge-
nous CDKL5 extended more than one axon (Fig 5A and 5B; means ±SEM: polarized, 48.5
±4.11; multiple axons, 45.37±2.93), but this effect was significantly attenuated by the silencing
of shootin1. Indeed, depletion of shootin1 in conjunction with exogenous CDKL5 expression
significantly reduced the number of neurons with a surplus of axons (means ±SEM: polarized,
73.2±6.18; multiple axons 17.37±6.98). As control, we confirmed that the silencing of shootin1
in GFP-expressing neurons generated an increased number of neurons with no axon (means
±SEM: polarized, 61.5±8.09; no axon, 32.67±7.52).
These experiments demonstrate that CDKL5 induces multiple axons only when proper lev-
els of shootin1 are present, suggesting that indeed CDKL5 works upstream shootin1 in the reg-
ulation of axon specification.
Previous reports stated that shootin1 is phosphorylated in hippocampal neurons [23] and,
recently, that its PAK1-mediated phosphorylation regulates the traction forces required for
axonal outgrowth [24]. We hypothesized that CDKL5 regulates shootin1 activity in a phos-
phorylation-dependent manner. Therefore, we first analyzed whether the phosphorylation of
shootin1 in primary cortical neurons could be detected by two-dimensional SDS-polyacryl-
amide gel electrophoresis (SDS-PAGE). As shown in Fig 6A (upper panel), shootin1 was
resolved in seven distinct spots with different isolectric points. Importantly, samples treated
with lambda phosphatase (λ-PPase; lower panel) showed reduced intensity of the two most
acidic spots (6 and 7), confirming that they correspond to phospho-isoforms of shootin1.
We then silenced the expression of the kinase by infecting cortical neurons at the time of
plating with shCDKL5#1-expressing lentiviral particles to analyze the role of CDKL5 in the
post-translational modifications of shootin1 using the single spot of neurofilament (NFL) as
internal standard for alignment. Interestingly, a reduction in signal intensity of the two most
acidic spots, corresponding to the two shootin1 phospho-isoforms, was easily detected when
Axon Formation Is Controlled by CDKL5
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CDKL5 was silenced (Fig 6B). Consistently, the phosphorylation profile of shootin1 generated
from cortices of Cdkl5-null mice [13] was altered compared to that of control animals, with a
clear accumulation of the more basic isoforms when the kinase was missing (S4 Fig).
Altogether, these experiments confirm a model according to which CDKL5 works upstream
shootin1, directly or indirectly affecting its phosphorylation.
Discussion
Mutations in the X-linked CDKL5 gene have been identified in patients with the early onset sei-
zure variant of Rett syndrome and other neurological disorders sharing common features such
as the appearance of intractable seizures during the first months of life, infantile spasms, hypo-
tonia, and severe intellectual disabilities [2]. The biological functions of CDKL5 are barely
understood and only recently the neurological dysfunctions underlying the etiology of CDKL5
associated disorders have become clearer [1]. However, the expression pattern of CDKL5 sug-
gests that it plays a role during early steps of post-natal differentiation and this might, at least
in part, fit with the precocious symptoms of CDKL5-related pathologies. Neuronal develop-
ment relies on a finely tuned interplay between polarization and migration leading to the
acquirement of the final neuronal specificity, independently of the neuronal type or brain area
analyzed. Subtle deficits in such processes are associated with both epilepsy and autism. It is
thus intriguing to speculate that both these features, which represent characteristic phenotypes
of patients with mutations in CDKL5, might, to some extent, originate from such deficits. A
delay in the migration of cortical neuronal precursors devoid of CDKL5 has already been
reported [9,10]. This supports the idea that defective CDKL5 activity might affect early steps of
differentiation by altering molecular processes resulting in a delayed refinement of cortical
architecture, besides impacting on cytoskeletal modifications. Moreover, recent observations
reporting that CDKL5 regulates neuronal morphology in cultured neurons [9,10] have been
further extended in vivo by the observation that cortical and hippocampal neurons in Cdkl5-
null brains display reduced arborization [13,25].
Here we show that proper CDKL5 levels are crucial also for axonal specification and elonga-
tion. The silencing of CDKL5 results in an increased number of neurons bearing no axon while
both silencing and overexpression of the kinase are associated with the formation of supernu-
merary axons and reduced axonal length. This is the first time that a role of CDKL5 in neuronal
polarization is reported. Nevertheless, it is relevant to mention that a role in regulating neurite
outgrowth, rather than axon specification, has previously been reported for CDKL5 [9]. We
believe that the different timing of the silencing/overexpression and morphological analyses
and the variability between cortical rat and hippocampal murine neuronal cultures [26] may
explain the different results. In agreement with our data, showing that increased CDKL5 levels
induce the formation of a surplus of axons, duplications of genomic regions encompassing
CDKL5 have recently been identified in patients with neurological deficits that include autistic
traits [27].
Fig 4. CDKL5 promotes axon formation. (A) Western blot showing CDKL5 levels in primary hippocampal neurons nucleofected before plating with
bicistronic vectors expressing GFP alone or together with CDKL5 or CDKL5-K42R. Cell lysates were prepared at DIV5 and analyzed for CDKL5 levels using
Tuj1 as loading control. (B) Representative images showing the localization of endogenous and exogenous CDKL5 in the soma of nucleofected GFP-positive
neurons at DIV5. The exposure time of the GFP-expressing neuron (left) was increased to reveal the staining of endogenous CDKL5. (C) Representative
images showing hippocampal neurons at DIV5 transfected with vectors expressing GFP together with CDKL5 or the K42R derivative. GFP and CDKL5
signals are in green and red, respectively. The arrows indicate neurons with increased CDKL5 levels. Scale bar: 20 μm. (D) Quantitative analysis of neuronal
polarization. Axon specification was analyzed at DIV5 by determining the number of neurons with a single axon (polarized, black bars), multiple axons (dark
grey bars) and neurons with no axon (light grey bars). Data are expressed as mean of 4 independent experiments ±SEM; ***p<0,001, **p<0,01, *p<0,05
(n100 neurons/condition, Student’s t test). (E) Graph showing the length of the longest axon and dendrite of transfected neurons. Data present neurite
length as means ±SEM (n>28 neurons/condition, 4 independent experiments); **p<0,01. (Student’s t test).
doi:10.1371/journal.pone.0148634.g004
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Fig 5. CDKL5 regulates axon outgrowth through shootin1. (A) Immunofluorescence of neurons
nucleofected before plating with a bicistronic vector expressing GFP alone or together with CDKL5 and
subsequently infected with lentiviral particles expressing shRNAs against shootin1 or LacZ. At DIV5 neurons
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Since the molecular mechanisms by which CDKL5 regulates neuronal functions are far
from understood, we aimed at identifying novel CDKL5 interactors that might help addressing
this point. In a yeast two-hybrid screening we identified shootin1 as a novel interactor of
CDKL5. Shootin1 is a brain-specific protein acting as a determinant of axon formation during
the process of neuronal polarization. In unpolarized rat hippocampal neurons, shootin1 ran-
domly fluctuates in the growth cones of multiple neuritis, eventually accumulating in a single
neurite before its outgrowth as an axon [17]. Importantly, silencing and overexpression studies
have established that shootin1 accumulation in the axon-to-be is both necessary and sufficient
for axon outgrowth. By analyzing in details the functional interplay between shootin1 and
CDKL5, we found evidence that CDKL5 is involved in regulating neuronal polarization, at
least in part, through its interaction with shootin1. We observed low but detectable levels of
CDKL5 in unpolarized hippocampal neurons and a strong induction in the transition from
were stained for GFP, Tau1, and CDKL5 (green, blue, and red, respectively). (B) Quantification of neuronal
polarization of GFP-positive neurons with increased CDKL5 expression. Data are expressed as means
±SEM. **p<0,01, *p<0,05. (n24 neurons/condition in 3 independent experiments; ANOVA two-way). Scale
bar: 20 μm.
doi:10.1371/journal.pone.0148634.g005
Fig 6. CDKL5 influences shootin1 phosphorylation in primary cortical neurons. (A) Total cell extracts of
DIV7 cortical neurons were treated with or without lambda phosphatase (λ-PPase) and analyzed by two-
dimensional gel electrophoresis and immunoblotting with antibodies against shootin1, β-actin and, as control
for the λ-PPase treatment, phopho-ERK1/2. (B) Primary cortical neurons were infected with shLacZ- or
shCDKL5#1-expressing viral particles at DIV0 and total cell lysates were prepared at DIV7 and subjected to
two-dimensional gel electrophoresis. Shootin1 and NFL were detected by immunoblotting; the single NFL-
spot was used as internal control for alignment. Silencing of CDKL5 was confirmed by western blot (right
panel). (n = 3).
doi:10.1371/journal.pone.0148634.g006
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stage 2 to stage 3, where it is present in the distal tip of neurites or outgrowing axons together
with shootin1. Moreover, we find that the two proteins associate in vivo in early post-natal
brains and that correct CDKL5 levels are required for proper axon formation. Similarly to
shootin1, the majority of hippocampal neurons over-expressing CDKL5 generates a surplus of
axons, whereas a significant number of neurons devoid of the kinase fails to correctly differen-
tiate a single axon. Importantly, the polarization defects observed in neurons with altered
CDKL5 expression can be ascribed, at least partially, to a functional interplay with shootin1. In
fact, the generation of supernumerary axons induced by CDKL5 is significantly attenuated when
shootin1 levels are reduced, confirming that the two proteins act in a common pathway and that
CDKL5 acts upstream shootin1. Consequently, we speculated that CDKL5 might influence shoo-
tin1 phosphorylation. This post-translational modification of shootin1 is known to be induced
by the activation of both Pak1 and cdc42/Rac1 and is required for its association with the actin
retrograde flow, allowing the formation of traction forces at axonal growth cones [24]. To sup-
port this hypothesis, the catalytically inactive form of CDKL5 (K42R) causes an attenuation of
the polarization phenotype induced by the wild-type kinase, suggesting that the catalytic activity
of CDKL5 is, at least in part, involved in the observed polarization defects. Moreover, shootin1
phosphorylation is reduced both in neurons silenced for CDKL5 as well as in Cdkl5-null cortices,
reinforcing the idea that the two proteins work in a common molecular pathway.
As a possible scenario, we hypothesize that the absence of CDKL5 reduces the traction force
by altering the phosphorylation state of shootin1, thus causing a reduction of axon length.
Whether CDKL5 phosphorylates shootin1 directly or through an intermediary kinase remains
to be revealed as well as the specific residues of shootin1 whose modification depends on
CDKL5. It is interesting to note that Rac1 appears to be common to the pathways of both
CDKL5 and shootin1. As mentioned, shootin1 phosphorylation is induced by cdc42/Rac1-de-
pendent Pak1 activation and CDKL5 has been reported to regulate neuronal morphology act-
ing upstream Rac1 [9,24]. In the future, it will be interesting to analyze whether CDKL5 exerts
its regulatory functions on shootin1 in a Rac1-dependent manner.
Even if the main body of our experiments is in line with a role of CDKL5 in neuronal polari-
zation through its association with shootin1, the picture is complicated by the fact that silenc-
ing of CDKL5 generates a mixed phenotype including both neurons devoid of axons and
neurons with numerous axons. CDKL5 is very likely to influence different downstream path-
ways through its different interaction partners and may thus target different factors involved in
regulating axon specification and outgrowth. In this scenario, we believe that CDKL5 influ-
ences neuronal polarization in part through shootin1 and in part in a shootin1-independent
manner. Disruption of the shootin1-dependent mechanism generates neurons devoid of axons
and a concomitant reduction in axon elongation of properly polarized neurons. This defect
seems to be a mere delay in axon outgrowth and elongation since the percentage of neurons
with no axon returns to control levels at DIV7, as also reported for neurons with reduced shoo-
tin1 levels [24]. Conversely, the impairment of the other pathway, which still remains to be
identified, results in excessive axon formation and persists at DIV7.
A kinome profiling of brain extracts from Cdkl5-null mice revealed that several signaling
pathways are deregulated in its absence [12]. Interestingly, the three pathways that were mostly
influenced were those including AMPK kinase, PKA, and AKT that are all involved in neuronal
polarization [12]. Accordingly, the activity of GSK3-β, a downstream effector of AKT, is altered
in Cdkl5-null mice [25], whereas, a pleiotropic effect of GSK3-β on neuronal polarization has
already been demonstrated [28]. In the future, it will be intriguing to elucidate the contribution
of GSK3β in the polarization defects associated with CDKL5. Moreover, as mentioned, CDKL5
works upstream of Rac1 [9] and it is well established that Rac1 influences various aspects of
neuronal morphogenesis through different upstream regulators and downstream effectors.
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Axon initiation is mediated by Rac1 in a pathway involving DOCK7 and stathmin whereas this
small Rho GTPase appears to have a dual role in regulating axon outgrowth. Its inhibitory
activity requires a pathway including PAK, LIMK, and cofilin whereas growth promotion is
PAK-independent [29]. Finally, it is possible that the silencing of CDKL5 has different effi-
ciency and/or timing in different neurons thus influencing its downstream effectors in distinct
time windows with opposing outcomes.
Altogether, our data indicate a so far uncharacterized role of CDKL5 in the early phases of
neuronal differentiation that may concur to the clinical features associated with mutations in
this gene. Finally, both the association of shootin1 with a molecular pathway belonging to
CDKL5 and the defects in neuronal migration previously associated with its deficiency [30]
might make shootin1 an interesting candidate gene for neurological disorders.
Supporting Information
S1 Fig. CDKL5 localization in neurites and axons of hippocampal neurons. (A) Immunoflu-
orescence analysis of primary hippocampal neurons expressing GFP (green) at stages 2–3 with
anti-CDKL5 (red). Quantitative profiles showing the fluorescence intensities of GFP (green)
and CDKL5 (red) from the soma to the distal tip of the neurites/axons indicated with asterisks
are shown to the right. CDKL5 is present in the distal tip of the axon without showing a specific
accumulation. (B) Hippocampal neurons were infected at the day of plating with lentiviral par-
ticles expressing two different shRNAs against CDKL5 or, as control, against LacZ. At DIV4,
neurons were stained for CDKL5 (red); GFP is in green. The signal intensity of CDKL5 was
analyzed with ImageJ and the mean values plotted in the graph to the right. n = 30.
(TIF)
S2 Fig. Aberrant neuronal polarization in the absence of CDKL5. Immuofluorescence of
DIV4 hippocampal neurons expressing shRNAs against LacZ or CDKL5. Polarized neurons
extend one Tau1-positive and MAP2-negative axon. Neurons silenced for CDKL5 present
supernumerary axons (middle column) or do not extend any axon (right column). Tau1,
MAP2 and GFP are in blue, red and green, respectively.
(TIF)
S3 Fig. Neuronal polarization defects caused by CDKL5 silencing persist at DIV7. Graphs
showing polarization of hippocampal neurons expressing shRNAs against CDKL5 or LacZ at
DIV4 and DIV7. The graphs show the percentage of polarized neurons, neurons with multiple
axons and with no axon at the two different time points as means ±SEM (n3, a total of>100
neurons were analyzed). p<0,001, p<0,01, p<0,05. (Student’s t test).
(TIF)
S4 Fig. Altered shootin1 phosphorylation in Cdkl5-null cortices. Cortices of P5 wild-type
and Cdkl5-null mice were lysed in Tris pH 7.4, NaCl 150 mM, CHAPs 0.5%, EDTA 0.2 mM,
PMSF 1 mM, inhibitors of proteases and phosphatases and treated or not with λ-PPase.
Nucleic acids and lipids, possibly interfering with 2-DE, were removed by centrifugation in
ultrafiltration concentration devices (Vivaspin 500 MWCO 3000 Da PES, Sartorius) at 15000 g
to a final volume of 100 μl. Samples were subsequently diluted in UTC (7 M urea, 2 M thiourea,
4% CHAPS) and 200 μg of proteins were subjected to isoelectric focusing. The subsequent
immunoblotting was performed first against shootin1 and next against neurofilament (NFL;
MA5-14981, Thermo Scientific, diluted 1:1000 in 5% non-fat milk in TBST) without stripping
the membrane for the anti-shootin1 antibodies. The NFL signal could thus be used as internal
standard for alignment. n = 2.
(TIF)
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